Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 3

Adagene announced its poster presentation at the SITC 38th Annual Meeting taking place November 1-5, 2023 in San Diego

Related Keywords

San Diego ,California ,United States ,Singapore ,Australia ,China ,Japan ,San Diego Convention Center ,Suzhou ,Jiangsu , ,Twitter ,Linkedin ,European Union ,Dynamic Precision Library ,Nasdaq ,Exchange Commission ,Adagene Inc ,Annual Meeting ,Optimal Dose Selection ,Significantly Widened Therapeutic Index ,Hall Hours ,Exhibit Halls ,San Diego Convention ,Media Contact ,Ami Knoefler ,Adagene ,Poster Presentation ,Itc 38th Annual Meeting ,November ,